Daniel Vapnek

Daniel Vapnek

Corporate Officer/Principal at
University of California, Santa Barbara
87 year
Health Technology
Consumer Services

Profile

Dr. Daniel Vapnek is an Advisor at Iguana Healthcare Management LLC.
He was Senior Vice president for Research at Amgen from 1981-1997.
During his tenure, scientists under his direction developed Epogen and Neupogen and discovered the RANK ligand which laid the groundwork for the development of denosumab for the treatment of osteoporosis.
For the past decade, Dr. Vapnek has been an advisor to venture capital funds and involved in several startups including BioArray solutions, which was recently sold to Immucor.
He is currently on The Board of Directors of Medicinova and an Adjunct Professor of Cellular and Molecular Biology at the University of California Santa Barbara.
Prior to joining Amgen, he was Professor of Molecular and Population Biology at the University of Georgia.
Dr. Vapnek received his undergraduate degree from the University of Miami (Florida) and a doctorate degree from the University of Miami (Florida).

Daniel Vapnek active positions

CompaniesPositionStart
Corporate Officer/Principal -

Former positions of Daniel Vapnek

CompaniesPositionEnd
Director/Board Member 2007-03-31
Protein Pathways, Inc.
Chairman 2004-10-31
ASPIRA WOMEN'S HEALTH INC. Director/Board Member 2001-04-30
AMGEN INC. Chief Tech/Sci/R&D Officer 1996-12-30
Corporate Officer/Principal -
See the detail of Daniel Vapnek's experience

Training of Daniel Vapnek

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

84

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Protein Pathways, Inc.